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Abstract
Background: A prolonged latent phase is independently associated with an increased incidence of subsequent
labor abnormalities. We aimed to compare between oxytocin augmentation, amniotomy and a combination of
both on the duration of labor among women with a prolonged latent phase.
Methods: Women with a singleton fetus in cephalic presentation who have a prolonged latent phase, were
randomly allocated to amniotomy (group 1), oxytocin (group 2) or both (group 3). A group of women who
progressed spontaneously without intervention composed the control group (group 4). The primary outcome was
the duration of time from initiation of augmentation until delivery.
Results: A total of 213 women were consented and randomized to group 1 (70 women), group 2 (72 women)
and group 3 (71 women). Group 4 was composed from additional 70 women. A mean reduction of 120 minutes in
labor duration was observed among group 3 compared to group 1 (p = 0.08) and 180 minutes compared to
group 2 and 4 (p = 0.001). Women in group 3 had a shorter length of time from augmentation until the
beginning of the active phase and a shorter first stage of labor than group 1 (p = 0.03), group 2 (p = 0.001) and
group 4 (p = 0.001). Satisfaction was greater among group 3 and 4. Mode of delivery and neonatal outcome were
comparable between the groups.
Conclusion: Labor augmentation by combined amniotomy and oxytocin among women with a prolonged latent
phase at term seems superior compared to either of them alone.
Background
Arrested or prolonged labor is a frequent indication for
cesarean delivery [1,2]. Prolonged labor is also asso-
ciated with increased pain and negative birth experi-
ences [3,4]. Furthermore, women with a longer first
stage of labor have experienced a higher rate of postpar-
tum hemorrhage, chorioamnionitis and neonatal admis-
sion to the intensive care unit [5].
A prolonged latent phase is independently associated
with an increased incidence of subsequent labor
abnormalities, an increased rate of cesarean delivery,
thick meconium, depressed Apgar scores, and the need
for newborn resuscitation [6,7].
The incidence of a prolonged latent phase has been
reported to be three to four percent regardless of par-
ity [8]. Although the optimal management is uncertain,
augmentation of labor has been proposed as an ade-
quate approach to the problem of prolonged latent
phase, as well as a strategy to reduce the rate of cesar-
ean delivery [7]. This intervention is based on the
hypothesis that the most frequent cause of dystocia is
inadequate uterine contraction.
Oxytocin augmentation of uterine contractions with or
without amniotomy is widely used in the modern obste-
tric practice to treat a slow labor, although the timing of
oxytocin initiation and amniotomy may vary widely [9].
Our aim in this study was to compare among women
with a prolonged latent phase, the effect on the duration
of labor, of augmentation with oxytocin, amniotomy or a
combination of both.
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This prospective randomized trial was held from January
2006 to January 2009 in the labor and delivery ward of
the department of Obstetrics and Gynecology at Ha’E-
mek Medical Center in Afula, Israel, a university teach-
ing hospital.
Women at term (gestational age of 37 weeks or more)
with intact amniotic membranes and a singleton fetus in
cephalic presentation, who had a spontaneous onset of
labor, a cervical dilatation between two and four cm,
vertex level of no more than two cm above the pelvic
inlet and had a prolonged latent phase of labor were
included in the study. Gestational age was confirmed by
either a documented first trimester ultrasound or by
known regular last menstrual period and a documented
ultrasound in the second trimester.
The latent phase was defined as the interval between the
start of regular contractions (women’s report) combined
with any cervical dynamics (dilatation and/or effacement)
until the active phase of labor was established when cervi-
cal dilatation was greater than four cm. A prolonged latent
phase was defined as lasting more than 20 hours for primi-
parous women and 14 hours for multiparous women [10].
Women with a previous uterine scar, rupture of mem-
branes, placental abruption, severe preeclampsia,
suspected fetal macrosomia (greater than 4000 g), a non-
reassuring fetal heart rate tracing or any contraindication
for a trial of labor, were excluded. Women who had a
malformed fetus diagnosed in the antepartum period or
had an antepartum fetal death were also excluded.
Women with the diagnosis of prolonged latent phase
were randomly allocated to amniotomy (group 1), oxyto-
cin (group 2) or both (group 3). Amniotomy in group 1
was performed immediately after admission to the delivery
ward. If no progress in cervical dilatation was documented
after two hours or there were fewer than three contrac-
tions in ten minutes recorded after one hour, oxytocin was
added. In group 2, oxytocin was started immediately after
admission to the delivery ward. If no progress in cervical
dilatation was documented after two hours or there were
fewer than three contractions in ten minutes recorded
after 1 hour, amniotomy was performed. Group 3 had
both amniotomy and oxytocin performed and started
simultaneously after admission to the delivery ward. The
protocol of oxytocin administration was one mU/min
increased by one mU/min every 20 minutes until five con-
tractions in ten minutes or cervical progress was docu-
mented. When no progress was documented after two
hours despite five contractions in ten minutes, an internal
pressure catheter was inserted and oxytocin was increased
until a Montevideo score of 200 to 300 was achieved.
Randomization of the three groups was performed in
blocks of ten using a computer randomization sequence
generation program. The sequence was concealed until
intervention was assigned.
Women who were admitted in the latent phase of labor
to our labor ward and who progressed spontaneously
without intervention composed the control group
(group 4). The control group was selected by choosing
the women who met the inclusion criteria during the
study period. The purpose of selecting this group of
women is to compare the duration of the different labor
stages among the study groups to a spontaneously pro-
gressing women who did not need labor augmentation.
T h ep r i m a r yo u t c o m ew a st h ed u r a t i o no ft i m ef r o m
initiation of labor augmentation until delivery. Women
who were operated were excluded from the analysis of
the primary outcome. Secondary outcomes were active
phase duration, duration of first and second stages of
labor, mode of delivery, maternal fever, antibiotic
administration, postpartum hemorrhage, anal sphincter
tears, Apgar score and maternal satisfaction.
Women expressed their satisfaction using a score from
one (absolutely not satisfied) to five (absolutely satisfied).
The following variables were considered: maternal age, eth-
nicity, parity, antepartum obstetric complications (gesta-
tional diabetes, hypertension, antepartum bleeding,
thrombophilia, and oligohydramnios), epidural use, num-
ber of vaginal examinations, intra-partum fetal scalp-
electrode or uterine pressure catheter use and birth weight.
Continuous electronic fetal heart rate monitoring for
all groups was initiated and continued until delivery.
Arrest of dilatation during the active phase was deter-
mined when the Montevideo score was between 200 and
300 for more than two hours. Arrest of descent was
defined as an arrest of descent of the fetal head for more
than one hour during the second stage of labor. When
arrest of descent was diagnosed at a level below the mid-
pelvis, a vacuum extraction was used, and when above
the midpelvis, a cesarean delivery was performed. All
groups were given standard care according to depart-
mental guidelines when it came to midwifery support, i.e.
1 midwife per 1 to 2 laboring women and access to pain
relief, i.e. epidural, intravenous pethidine and/or inhala-
tion of a mixture of O2 with N2O according to maternal
demand regardless of the measured cervical dilatation.
The study was approved by the local institutional
review board and each woman signed an informed
consent.
Statistical analysis
One way ANOVA or a Kruskal Wallis test in the case of
non-normally distributed variables was performed to
compare the continuous data of the four groups of
women. Chi-square or Fisher exact tests when appropri-
ate were used to compare the categorical data. Bonferroni
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Mann-Whitney pair-wise comparisons with p < 0.05 con-
sidered to be significant. In the case of non-normally dis-
tributed data, Kruskal-Wallis test was used to determine
pair-wise differences among statistically significant and
borderline statistically significant variables. This analysis
was repeated for primiparous and for multiparous
women.
Mean time interval from initiation of augmentation
until delivery was eight hours (±120 minutes), based on
previous observation at our delivery ward. Accordingly,
in order to demonstrate a difference of one hour between
group three compared to group one and two with an
a l p h ao f0 . 0 5a n dap o w e ro f9 0 % ,as a m p l es i z eo f6 3
women per group was required. The primary analysis
was performed on the groups as allocated, that is, by the
intention to treat, including all women as randomized.
Results
Of 12,571 women who delivered during the study period,
377 (3%) had a prolonged latent phase. After excluding
97 ineligible women, 280 women fulfilled the inclusion
criteria and were invited to participate in the study. Of
them 213 consented and were randomized (Figure 1).
Seventy women composed the control group (group 4).
The four groups were demographically similar and
had no statistically significant differences in pre-delivery
parameters (table 1). Length of time from augmentation
until delivery was significantly different between the 3
study groups. Post hoc testing revealed that women in
group 3 had a statistically shorter labor than groups 2
and 4 (p = 0.001) and tended to have a shorter labor
than group 1 (p = 0.08).
The four groups differed significantly in the length of
time of the first stage and the length of time from aug-
mentation until the beginning of the active phase (p =
0.001). Post hoc testing revealed that women in group 3
had a shorter first stage of labor than group 1 (p =
0.03), group 2 (p = 0.001) and group 4 (p = 0.001). This
difference was also found in the length of time from
augmentation until the beginning of the active phase.
The four groups differed in the frequency of intrapar-
tum fever (p = 0.03) and in antibiotic use (table 1); how-
ever post hoc pairwise comparisons did not find any
significant differences between the groups in the fre-
quency of intrapartum fever and in antibiotic use.
Figure 1 Flow diagram of participants.
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examinations (p = 0.02). Post hoc testing revealed that
the women in group 3 had fewer vaginal examinations
than either of the single augmentation groups (group 1:
p = 0.02; group 2: p = 0.007) but did not differ from the
control group.
There was a statistically significant difference in women
satisfaction among the four groups (p = 0.01). Post hoc
testing showed that the control group was more satisfied
than groups 1, 2 (p = 0.001) and 3 (p = 0.02). In addition
group 3 was more satisfied than group 2 (p = 0.007).
Primiparous women
Of all women recruited, 80 were primiparous (table 2).
T h ef o u rg r o u p sw e r ed e m o g r a p h i c a l l ys i m i l a r .T h e r e
were no statistically significant differences in pre-deliv-
ery parameters between the groups.
Length of time from augmentation until delivery was
significantly different between the groups among primi-
parous women (p = 0.005). Post hoc testing revealed
that women in group 3 had a statistically shorter labor
t h a ng r o u p4( p=0 . 0 0 1 )a n d1( p=0 . 0 4 ) ,a n dt e n d e d
to have a shorter labor than group 2 (p = 0.08).
Table 1 Demographic and obstetric characteristics of all women by treatment group
Group 1
(Amniotomy)
Group 2
(Oxytocin)
Group 3 (Amniotomy and
Oxytocin)
Group 4
(Control)
Obstetric and demographic data N = 70 N = 72 N = 71 N = 70 p
Maternal age, years 28.1 ± 4.9 (28) 28.5 ± 5.3 (27) 28.2 ± 5.0 (28) 28.7 ± 4.7 (29) 0.9
Gestational age, weeks 39.6 ± 1.1 (39.6) 39.6 ± 1.2 (39.6) 39.6 ± 1.1 (40) 39.7 ± 1.0 (39.6) 0.9
Parity 2.5 ± 1.3 (2) 2.5 ± 1.3 (2) 2.6 ± 1.4 (2) 2.2 ± 1.2 (2) 0.2
BMI (pre pregnancy) kg/m
2 24.6 ± 4.8 (23) 23.3 ± 3.5 (23) 25.4 ± 5.6 (24) 23.5 ± 4.1 (23) 0.09
Weight gain, kg 12.2 ± 5.7 (12) 13.0 ± 5.6 (13) 12.5 ± 5.1 (12) 13.6 ± 5.1 (13) 0.5
Cervical dilatation, cm 3.0 ± 0.4 (3) 2.8 ± 0.4 (3) 3.0 ± 0.4 (3) 3.0 ± 1.0 (3) 0.3
Intra-partum fever 3 (4) 0 (0.0) 0 (0.0) 0 (0.0) 0.03
Antibiotics use 4 (6) 0 (0.0) 0 (0.0) 0 (0.0) 0.007
Epidural use 18 (26) 23 (32) 18 (25) 21 (30) 0.9
Fetal scalp pH 1 (1) 0 (0.0) 0 (0.0) 0 (0.0) 0.5
Vaginal examinations 6.0 ± 2.8 (5)
a 6.1 ± 2.4 (6)
a 4.8 ± 1.6 (5) 5.6 ± 2.0 (6) 0.02
Fetal Scalp electrode 10 (14) 3 (4) 12 (17)
c 15 (21)
c 0.02
Intra-uterine pressure catheter 4 (6) 2 (3) 0 (0.0) 1 (1) 0.1
Time from enrollment until delivery, min 431 ± 346 (320) 494 ± 327
(396)
a
312 ± 245 (246) 498 ± 306
(390)
a
0.001
Duration of the first stage of labor, min 403 ± 327 (273)
a 463 ± 313
(387)
a
283 ± 233 (222) 460 ± 285
(371)
a
0.001
Time from enrollment until the beginning of the
active phase, min
284 ± 296 (180)
a 361 ± 303
(278)
a
183 ± 222 (109) 333 ± 270
(265)
a
0.001
Duration of the active phase, min 118 ± 115 (85) 103 ± 89 (78) 101 ± 65 (89) 127 ± 96 (101) 0.3
Duration of the second stage, min 32 ± 51 (10) 31 ± 46 (10) 28 ± 41 (10) 38 ± 54 (12) 0.7
Delivery mode 0.8
Spontaneous vaginal 65 (93) 68 (94) 66 (93) 68 (97) –
Vacuum 3 (4) 2 (3) 4 (6) 1 (1) –
Cesarean 2 (3) 2 (3) 1 (1) 1 (1) 0.9
Vacuum or cesarean 5 (7) 4 (6) 5 (7) 2 (3) 0.6
Early post partum hemorrhage 0 (0.0) 3 (4) 3 (4) 0 (0.0) 0.09
Anal sphincter tear 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1.0
Post-partum fever 1 (1) 0 (0.0) 0 (0.0) 0 (0.0) 0.5
Women satisfaction 4.7 ± 0.6
b 4.7 ± 0.6
b 4.9 ± 0.5
b 5.0 ± 0.1 0.001
Birthweight, gr 3371 ± 424 (3377) 3386 ± 434
(3350)
3419 ± 409 (3376) 3309 ± 385
(3289)
0.5
Apgar score at 5 min 10.0 ± 0.2 10.0 ± 0.3 9.9 ± 0.2 10.0 ± 0.3 0.9
Data are mean ± standard deviation (median) or n (%) unless otherwise specified.
a, statistical difference (p < 0.05) was found when compared with group 3 after post hoc testing.
b, statistical difference (p < 0.05) was found when compared with group 4 after post hoc testing.
c, statistical difference (p < 0.05) was found when compared with group 2 after post hoc testing.
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time of the first stage (p = 0.003), the length of time from
augmentation until the beginning of the active phase (p =
0.009) and the active phase duration (p = 0.02). Post hoc
testing revealed that women in group 3 had a shorter first
stage of labor than the control group (p = 0.001), group 2
(p = 0.01) and group 1 (p = 0.02). This difference was also
found in the length of time from augmentation until the
beginning of the active phase (control: p = 0.004; group 1:
p = 0.01; group 2: p = 0.003). Post hoc testing of the active
phase differences revealed that the active phase was
shorter among group 2 than the control group (p = 0.002).
The four groups differed in the frequency of intrapar-
tum fever (p = 0.03) and in antibiotic use; however post
hoc pairwise testing did not find any significant differ-
ences between any of the augmentation methods. The
four groups differed in the number of vaginal examina-
tions (p = 0.009). Post hoc testing revealed that the
women in group 3 had less vaginal examinations than
women in group 1 (p = 0.001). Finally, there was a
statistically significant difference in women satisfaction
among the four groups (p = 0.002). Post hoc testing
showed that the women in group 4 were more satisfied
than women in groups 1 and 2 (group 1: p = 0.04; group
2: p = 0.01) yet not different than the women in group 3.
Multiparous women
Of all women recruited, 203 were multiparous (table 3).
T h ef o u rg r o u p sw e r ed e m o g r a p h i c a l l ys i m i l a r .T h e r e
were no statistically significant differences in the pre-
delivery variables between the groups.
Length of time from augmentation until delivery was
significantly different between the groups for multipar-
ous women (p = 0.001). Post hoc testing revealed that
women in group 3 had a significantly shorter labor than
groups 2 and 4 (p = 0.001, p = 0.004) yet not signifi-
cantly different than group 1. Group 1 had a signifi-
cantly shorter labor than group 2 (p = 0.008).
The four groups significantly differed in the length of
time of the first stage (p = 0.001) and the length of time
Table 2 Demographic and obstetric characteristics of primiparous women by treatment group
Group 1
(Amniotomy)
Group 2
(Oxytocin)
Group 3 (Amniotomy and
Oxytocin)
Group 4
(Control)
Obstetric and demographic data N = 21 N = 20 N = 16 N = 23 p
Intra-partum fever 3 (14) 0 (0.0) 0 (0.0) 0 (0.0) 0.03
Antibiotics use 3 (14) 0 (0.0) 0 (0.0) 0 (0.0) 0.03
Epidural use 12 (57) 8 (40) 7 (44) 11 (48) 0.7
Fetal scalp pH 1 (5) 0 (0.0) 0 (0.0) 0 (0.0) 0.7
Vaginal examinations 8.2 ± 3.5 (7)
a 6.4 ± 1.8 (6) 5.1 ± 1.2 (5) 6.7 ± 2.0 (7) 0.009
Fetal Scalp electrode 7 (33) 2 (10) 4 (25) 7 (30) 0.3
Intra-uterine pressure catheter 4 (19) 0 (0.0) 0 (0.0) 0 (0.0) 0.008
Time from enrollment until delivery, min 629 ± 338 (545)
a 590 ± 367 (444) 420 ± 319 (363) 740 ± 294
(689)
a
0.005
Duration of the first stage of labor, min 555 ± 307 (506)
a 533 ± 359
(409)
a
351 ± 327 (253) 651 ± 391
(580)
a
0.003
Time from enrollment until the beginning of the
active phase, min
339 ± 349 (298)
a 426 ± 372
(303)
a
206 ± 298 (105) 435 ± 305
(370)
a
0.009
Duration of the active phase, min 216 ± 161 (153) 114 ± 54 (119)
b 139 ± 84 (140) 205 ± 104
(178)
0.01
Duration of the second stage, min 75 ± 64 (51) 57 ± 65 (32) 69 ± 49 (50) 89 ± 66 (86) 0.4
Delivery mode 0.5
Spontaneous vaginal 16 (76) 17 (85) 14 (88) 22 (96) –
Vacuum 3 (14) 2 (10) 2 (13) 1 (4) –
Cesarean 2 (10) 1 (5) 0 (0) 0 (0) 0.4
Vacuum or cesarean 5 (24) 3 (15) 2 (13) 1 (4) 0.3
Early post partum hemorrhage 0 (0.0) 1 (5) 0 (0.0) 0 (0.0) 0.5
Post-partum fever 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) –
Women satisfaction 4.4 ± 0.9 (5) 4.4 ± 0.7 (4)
b 4.8 ± 0.5 (5) 5.0 ± 0.2 (5) 0.002
Birthweight, gr 3266 ± 487 (3334) 3257 ± 297
(3314)
3480 ± 385 (3428) 3337 ± 424
(3298)
0.4
Apgar score at 5 min 10.0 ± 0.2 10.0 ± 0.2 9.9 ± 0.2 9.9 ± 0.4 1.0
Data are mean ± standard deviation (median) or n (%) unless otherwise specified.
a, statistical difference (p < 0.05) was found when compared with group 3 after post hoc testing.
b, statistical difference (p < 0.05) was found when compared with group 4 after post hoc testing.
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phase (p = 0.001). Post hoc testing revealed that women
in group 3 had a shorter first stage of labor than
group 2 (p = 0.001) and group 4 (p = 0.004). This differ-
ence was also found in the length of time from augmen-
tation until the beginning of the active phase (group 2:
p = 0.001, group 4: p = 0.003). Women in group 3 had
no difference in the length of first stage of labor or the
length of time from augmentation until the beginning of
the active phase than group 1.
The four groups differed in the frequency of usage of
a scalp electrode (p = 0.03). Women in group 2 required
as c a l pe l e c t r o d el e s so f t e nt h a nt h ew o m e ni ng r o u p3
(p = 0.03) or 4 (p = 0.01).
There was a statistically significant difference in
women satisfaction among the four groups (p = 0.01).
Post hoc testing showed that the control group was more
satisfied than group 1 and 2 (group 1: p = 0.007; group 2:
p = 0.001), yet not different than the women in group 3.
Discussion
The incidence of prolonged latent phase has been reported
to be three to four percent regardless of parity [8]. While
Friedman did not find that prolongation of the latent
phase adversely influence maternal or fetal outcome [11],
others reported an increased incidence of subsequent
labor abnormalities, increased rate of cesarean delivery,
thick meconium and depressed newborn [6,7]. The opti-
mal management of a prolonged latent phase is uncertain
and several authors have called for further studies by
means of randomized controlled trials [7].
Since inefficient uterine contractions is the most com-
mon cause of poor progress [12], we compared, in this
randomized controlled trial between amniotomy, oxytocin
or a combination of both among women with a prolonged
latent phase. We investigated the effect of each interven-
tion on the duration of labor and on maternal and neona-
tal outcomes. Our results indicated that combined
oxytocin and amniotomy resulted in a shorter labor
Table 3 Demographic and obstetric characteristics of multiparous women by treatment group
Group 1
(Amniotomy)
Group 2
(Oxytocin)
Group 3 (Amniotomy and
Oxytocin)
Group 4
(Control)
Obstetric and demographic data N = 49 N = 52 N = 55 N = 47 p
Intra-partum fever 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) –
Antibiotics use 1 (2) 0 (0.0) 0 (0.0) 0 (0.0) 0.5
Epidural use 6 (12) 15 (29) 11 (20) 10 (21) 0.2
Fetal scalp pH 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) –
Vaginal examinations 5.0 ± 1.7 (5) 6.0 ± 2.6 (5) 4.8 ± 1.7 (5) 5.0 ± 1.7 (5.0) 0.1
Fetal Scalp electrode 3 (6) 1 (2) 8 (15)
d 8 (17)
d 0.03
Intra-uterine pressure catheter 0 (0.0) 2 (4) 0 (0.0) 1 (2) 0.3
Time from enrollment until delivery, min 352 ± 320 (241) 457 ± 305
(384)
a,c
279 ± 210 (227) 376 ± 232
(345)
a
0.001
Duration of the first stage of labor, min 337 ± 316 (230) 436 ± 292
(379)
a
262 ± 197 (214) 364 ± 230
(332)
a
0.001
Time from enrollment until the beginning of the
active phase, min
260 ± 313 (164) 336 ± 272
(276)
a
176 ± 197 (109) 279 ± 237
(233)
a
0.001
Duration of the active phase, min 76 ± 49 (70) 99 ± 99 (65) 90 ± 55 (81) 87 ± 61(75) 0.6
Duration of the second stage, min 15 ± 31 (8) 21 ± 32 (9) 16 ± 29 (10) 13 ± 15 (7) 0.5
Delivery mode 0.4
Spontaneous vaginal 49 (100) 51(98) 52 (95) 46 (98) –
Vacuum 0 (0) 0 (0) 2 (4) 0 (0) –
Cesarean 0 (0) 1 (2) 1 (2) 1 (2) 0.9
Vacuum or cesarean 0 (0) 1 (2) 3 (6) 1 (2) 0.4
Early post partum hemorrhage 0 (0.0) 2 (4) 3 (6) 0 (0.0) 0.2
Post-partum fever 1 (2.0) 0 (0.0) 0 (0.0) 0 (0.0) 0.5
Women satisfaction 4.9 ± 0.4 (5)
b 4.8 ± 0.5 (5)
b 4.9 ± 0.5 (5) 5.0 ± 0.0 (5) 0.01
Birthweight, gr 3416 ± 391 (3396) 3435 ± 470
(3456)
3401 ± 417 (3376) 3296 ± 368
(3282)
0.4
Apgar score at 5 min 10.0 ± 0.1 10.0 ± 0.3 10.0 ± 0.2 10.0 ± 0.2 0.8
Data are mean + standard deviation (median) or n (%) unless otherwise specified.
a, statistical difference (p < 0.05) was found when compared with group 3 after post hoc testing.
b, statistical difference (p < 0.05) was found when compared with group 4 after post hoc testing.
c, statistical difference (p < 0.05) was found when compared with group 1 after post hoc testing.
d, statistical difference (p < 0.05) was found when compared with group 2 after post hoc testing.
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alone. A mean reduction of 120 and 180 minutes in labor
duration when both methods of interventions were used
was observed compared to amniotomy alone or oxytocin
alone respectively. The main impact was observed from
the initiation of augmentation until the beginning of the
active phase. The effect on the duration of labor was evi-
dent among the whole group as well as in both primipar-
ous and multiparous women.
Mode of delivery did not differ between the groups,
and was comparable to the mode of delivery among a
control group of women who progressed spontaneously
without intervention. Post partum complications and
neonatal outcome were also comparable. The overall
low rate of cesarean section and post partum complica-
tions observed in this study is probably due to the fact
that low risk women were primarily included other than
them having a prolonged latent phase.
The mean number of vaginal examinations was lower
among women in the combined augmentation group com-
pared to either of them alone. This observation is probably
attributed to the shorter length of labor duration. Both the
shorter duration of labor and fewer vaginal examinations
probably contributed to a greater satisfaction observed
among both primiparous and multiparous women. More-
over, when both amniotomy and oxytocin were used,
labor duration was shorter and women satisfaction and
neonatal outcome were similar to a control group of
women who progressed spontaneously without interven-
tion. Since, there is no physiologic difference between oxy-
tocin-stimulated labor and natural labor [13], shorter labor
among women who have augmentation of labor with both
oxytocin and amniotomy may be explained by probably an
exposure to a higher overall dosage of oxytocin compared
to spontaneously progressing women. This observation is
supported by studies that compared between low versus
high dose oxytocin regimens for augmentation of labor
and which reported that a higher dosage regimen was
associated with a significantly shorter labors [13,14].
Contradictory results have been reported regarding the
effect of augmentation of labor on the length of labor
duration, mode of delivery and neonatal outcome
[15-19]. Our results regarding shortening of labor dura-
tion and a lack of difference in the operative delivery
rate between the groups corresponds well to earlier con-
clusions [16-18].
Oxytocin augmentation of uterine contractions com-
bined with or without amniotomy is widely used to treat
slow labor, although the exact timing of initiation and
their combination varies widely. Beside, intervention is
not always without risks. Intervention with oxytocin has
been associated with uterine hyperstimulation and fetal
heart rate abnormalities [20], while amniotomy was
associated with increased infectious morbidity [21]. The
common practice of including amniotomy as a comple-
ment to oxytocin for labor augmentation could mask
the benefits as well as the risks of each intervention
[16-18,22]. The strength of this study is that we were
able to isolate the impact of early oxytocin administra-
tion compared to amniotomy or both as the main con-
trasts between the groups. Furthermore, we added a
fourth group of normally progressing women to check
the duration of a spontaneously progressing labor and
to compare it with the length of labor among the study
groups. The comparison may assist physicians when
counseling women regarding labor duration before aug-
mentation is attempted. Although other maternal and
neonatal outcomes were comparable between the
groups, the study was not powered to detect outcomes
other than the duration of labor.
Conclusion
Augmentation of the contractile effort is mandated to
enable labor to progress to a normal vaginal delivery
among women with prolonged latent phase. In this
situation, combined oxytocin and amniotomy seems
superior compared to either of them alone.
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